Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsPublicly listed PT Waskita Karya recorded an extra Rp 3 trillion (US$201 million) of revenue in 2022 compared with the previous year but its net loss swelled by a considerable margin for the full-year figure.
Bukalapak has turned in yet another positive performance this year as the company managed to grow its year-on-year (yoy) revenue by 86 percent as of the third quarter, as announced in a press statement about the company’s financial report released on Sunday.
The pharmaceutical company saw revenue rise 6.6 percent yoy to Rp 12.37 trillion in the January-June period, supported by higher sales in its distribution services, prescription drug and consumer health product segments. The nutritional segment booked a decline.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.